Clinical Trial Update: CellCept in p-ANCA Vasculitis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating mycophenolate mofetil (CellCept) for MPO-ANCA-associated vasculitis and microscopic polyangiitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microscopic Polyangiitis
• Mpo-anca Vasculitis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: MPO-ANCA Vasculitis, Microscopic Polyangiitis | Phase 1 | Status: COMPLETED